WNT5A and neurogenic arthropathy: For the first time significant changes in gene expression of the Wnt signaling pathway – namely WNT3A, WNT5A, TCF7L2 and osteocalcin- in the bone of patients suffering from T2DM and following Charcot arthropathy could be shown.